Adults with moderate to severe plaque psoriasis saw the greatest mean quality-of-life gains with biologic therapy whereas home phototherapy offered lower costs for patients and payers, according to a ...

DNA Dermatology & Aesthetics has launched a new clinic in Jubilee Hills, Hyderabad. Founded by Dr Priyanka Reddy, the facility aims to offer advanced dermatology treatments and aesthetic services usin ...

PDRN, a bioactive molecule, has gained popularity in Korea. It is commonly used in treatments designed to restore skin ...

Hair fall, acne scars and pigmentation are pushing more people towards clinical dermatology treatments rather than relying ...

The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced that its first-in-class approach for treating hair loss with investigational medicine PP405 will ...

It is theorized that probiotics improve skin barrier hydration through multiple mechanisms, including modulation of the skin microbiome,’ according to the authors.

The FDA has approved the first oral interleukin (IL)-23-targeted therapy for plaque psoriasis, Johnson & Johnson announced. The approval of icotrokinra (Icotyde) stipulates use in adults and children ...

Metropolitan Dermatology is proud to announce the opening of its newest office in Williamstown, New Jersey, marking the practice's 23rd location and expanding access to high-quality dermatologic care ...

Dermatologist Dr Joyce Park says hair loss is common and often treatable with a simple, consistent routine. She recommends focusing on proven treatments such as Minoxidil 5%, cautious use of tretinoin ...

Icotyde is the first targeted oral peptide IL‑23 receptor antagonist, designed to interrupt a core psoriasis inflammatory axis while avoiding injection-based administration typical of IL‑23 biologics.